NM_000787.4:c.1734C>T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_000787.4(DBH):​c.1734C>T​(p.Asn578Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0163 in 1,613,902 control chromosomes in the GnomAD database, including 258 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.013 ( 17 hom., cov: 32)
Exomes 𝑓: 0.017 ( 241 hom. )

Consequence

DBH
NM_000787.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.868

Publications

6 publications found
Variant links:
Genes affected
DBH (HGNC:2689): (dopamine beta-hydroxylase) The protein encoded by this gene is an oxidoreductase belonging to the copper type II, ascorbate-dependent monooxygenase family. The encoded protein, expressed in neuroscretory vesicles and chromaffin granules of the adrenal medulla, catalyzes the conversion of dopamine to norepinephrine, which functions as both a hormone and as the main neurotransmitter of the sympathetic nervous system. The enzyme encoded by this gene exists exists in both soluble and membrane-bound forms, depending on the absence or presence, respectively, of a signal peptide. Mutations in this gene cause dopamine beta-hydroxylate deficiency in human patients, characterized by deficits in autonomic and cardiovascular function, including hypotension and ptosis. Polymorphisms in this gene may play a role in a variety of psychiatric disorders. [provided by RefSeq, Aug 2017]
DBH Gene-Disease associations (from GenCC):
  • orthostatic hypotension 1
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BP6
Variant 9-133658327-C-T is Benign according to our data. Variant chr9-133658327-C-T is described in ClinVar as Benign. ClinVar VariationId is 365673.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.868 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0126 (1924/152246) while in subpopulation NFE AF = 0.0178 (1209/67996). AF 95% confidence interval is 0.0169. There are 17 homozygotes in GnomAd4. There are 933 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 17 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DBHNM_000787.4 linkc.1734C>T p.Asn578Asn synonymous_variant Exon 12 of 12 ENST00000393056.8 NP_000778.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DBHENST00000393056.8 linkc.1734C>T p.Asn578Asn synonymous_variant Exon 12 of 12 1 NM_000787.4 ENSP00000376776.2

Frequencies

GnomAD3 genomes
AF:
0.0126
AC:
1924
AN:
152128
Hom.:
17
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00364
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00877
Gnomad ASJ
AF:
0.0397
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.0122
Gnomad FIN
AF:
0.0180
Gnomad MID
AF:
0.0348
Gnomad NFE
AF:
0.0178
Gnomad OTH
AF:
0.0144
GnomAD2 exomes
AF:
0.0157
AC:
3899
AN:
248846
AF XY:
0.0164
show subpopulations
Gnomad AFR exome
AF:
0.00252
Gnomad AMR exome
AF:
0.00487
Gnomad ASJ exome
AF:
0.0446
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0176
Gnomad NFE exome
AF:
0.0203
Gnomad OTH exome
AF:
0.0185
GnomAD4 exome
AF:
0.0167
AC:
24356
AN:
1461656
Hom.:
241
Cov.:
31
AF XY:
0.0169
AC XY:
12287
AN XY:
727152
show subpopulations
African (AFR)
AF:
0.00281
AC:
94
AN:
33478
American (AMR)
AF:
0.00555
AC:
248
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.0439
AC:
1147
AN:
26122
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39696
South Asian (SAS)
AF:
0.0171
AC:
1475
AN:
86242
European-Finnish (FIN)
AF:
0.0187
AC:
998
AN:
53394
Middle Eastern (MID)
AF:
0.0370
AC:
213
AN:
5764
European-Non Finnish (NFE)
AF:
0.0173
AC:
19203
AN:
1111862
Other (OTH)
AF:
0.0162
AC:
977
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
1228
2456
3685
4913
6141
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
700
1400
2100
2800
3500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0126
AC:
1924
AN:
152246
Hom.:
17
Cov.:
32
AF XY:
0.0125
AC XY:
933
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.00363
AC:
151
AN:
41560
American (AMR)
AF:
0.00875
AC:
134
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.0397
AC:
138
AN:
3472
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5164
South Asian (SAS)
AF:
0.0125
AC:
60
AN:
4818
European-Finnish (FIN)
AF:
0.0180
AC:
191
AN:
10614
Middle Eastern (MID)
AF:
0.0340
AC:
10
AN:
294
European-Non Finnish (NFE)
AF:
0.0178
AC:
1209
AN:
67996
Other (OTH)
AF:
0.0142
AC:
30
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
89
178
267
356
445
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0165
Hom.:
15
Bravo
AF:
0.0115
Asia WGS
AF:
0.00664
AC:
23
AN:
3478
EpiCase
AF:
0.0168
EpiControl
AF:
0.0188

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Orthostatic hypotension 1 Benign:2
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

DBH-related disorder Benign:1
Jan 13, 2020
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.73
CADD
Benign
0.12
DANN
Benign
0.64
PhyloP100
-0.87
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs45446891; hg19: chr9-136523449; API